Genmab A/S
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Genmab A/S's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13% to $16,474,000,000. Profit margin reached 26%. Total operating expenses were $10,927,000,000.

Profit Margin

Genmab A/S (NASDAQ:GMAB): Profit margin
2014 850.38M 301.29M 35.43%
2015 1.13B 763.51M 67.39%
2016 1.81B 1.18B 65.36%
2017 2.36B 1.10B 46.65%
2018 3.02B 1.47B 48.66%
2019 5.36B 2.16B 40.37%
2020 10.11B 4.75B 47.06%
2021 8.48B 2.95B 34.86%
2022 14.59B 5.45B 37.36%
2023 16.47B 4.35B 26.42%

GMAB Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
16.47B14.59B8.48B10.11B5.36B3.02B2.36B1.81B1.13B850.38M
Cost of revenue
226M000000000
Gross profit
16.24B14.59B8.48B10.11B5.36B3.02B2.36B1.81B1.13B850.38M
Operating exp.
Research and development
7.63B5.56B4.18B3.13B2.38B1.43B874.27M660.87M487.65M505.67M
Selling and marketing
0000000000
Total operating expenses
10.92B8.23B5.46B3.79B2.72B1.64B1.02B763.28M402.66M585.20M
Operating income
5.32B6.35B3.01B6.31B2.63B1.38B1.34B1.05B730.37M265.17M
Other income (expenses), net
316M678M965M-409M221M231.68M-280.45M77.38M27.14M32.16M
Income before tax
5.63B7.03B3.98B5.90B2.85B1.61B1.06B1.13B757.52M297.34M
Income tax expense
1.28B1.51B975M1.14B693M139.83M-39.83M-56.85M-5.98M-3.95M
Net income
4.35B5.45B2.95B4.75B2.16B1.47B1.10B1.18B763.51M301.29M
Earnings per share
Basic EPS
66.0283.38467.334.42.41.811.981.310.54
Diluted EPS
66.0282.5945.547.2234.042.371.781.921.260.53
Data sourceData sourceData sourceData sourceData source